209 related articles for article (PubMed ID: 34190016)
1. Elevated asleep blood pressure and non-dipper 24h patterning best predict risk for heart failure that can be averted by bedtime hypertension chronotherapy: A review of the published literature.
Hermida RC; Mojón A; Fernández JR; Hermida-Ayala RG; Crespo JJ; Ríos MT; Domínguez-Sardiña M; Otero A; Smolensky MH
Chronobiol Int; 2023 Jan; 40(1):63-82. PubMed ID: 34190016
[TBL] [Abstract][Full Text] [Related]
2. Extent of asleep blood pressure reduction by hypertension medications is ingestion-time dependent: Systematic review and meta-analysis of published human trials.
Hermida RC; Mojón A; Hermida-Ayala RG; Smolensky MH; Fernández JR
Sleep Med Rev; 2021 Oct; 59():101454. PubMed ID: 33571840
[TBL] [Abstract][Full Text] [Related]
3. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
[TBL] [Abstract][Full Text] [Related]
4. Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease.
Crespo JJ; Piñeiro L; Otero A; Castiñeira C; Ríos MT; Regueiro A; Mojón A; Lorenzo S; Ayala DE; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):159-75. PubMed ID: 23098134
[TBL] [Abstract][Full Text] [Related]
5. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
[TBL] [Abstract][Full Text] [Related]
6. Guidelines for the design and conduct of human clinical trials on ingestion-time differences - chronopharmacology and chronotherapy - of hypertension medications.
Hermida RC; Smolensky MH; Balan H; Castriotta RJ; Crespo JJ; Dagan Y; El-Toukhy S; Fernández JR; FitzGerald GA; Fujimura A; Geng YJ; Hermida-Ayala RG; Machado AP; Menna-Barreto L; Mojón A; Otero A; Rudic RD; Schernhammer E; Skarke C; Steen TY; Young ME; Zhao X
Chronobiol Int; 2021 Jan; 38(1):1-26. PubMed ID: 33342316
[TBL] [Abstract][Full Text] [Related]
7. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
[TBL] [Abstract][Full Text] [Related]
8. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
Hermida RC
Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
[TBL] [Abstract][Full Text] [Related]
9. Hypertension: New perspective on its definition and clinical management by bedtime therapy substantially reduces cardiovascular disease risk.
Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH
Eur J Clin Invest; 2018 May; 48(5):e12909. PubMed ID: 29423914
[TBL] [Abstract][Full Text] [Related]
10. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
[TBL] [Abstract][Full Text] [Related]
11. Systematic review and quality evaluation of published human ingestion-time trials of blood pressure-lowering medications and their combinations.
Hermida RC; Hermida-Ayala RG; Mojón A; Smolensky MH; Fernández JR
Chronobiol Int; 2021 Oct; 38(10):1460-1476. PubMed ID: 34107831
[TBL] [Abstract][Full Text] [Related]
12. Sleep-time blood pressure: Unique sensitive prognostic marker of vascular risk and therapeutic target for prevention.
Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
Sleep Med Rev; 2017 Jun; 33():17-27. PubMed ID: 27316324
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
[TBL] [Abstract][Full Text] [Related]
14. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
[TBL] [Abstract][Full Text] [Related]
15. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals.
; ; ; ; ; Hermida RC; Smolensky MH; Ayala DE; Portaluppi F
Chronobiol Int; 2013 Apr; 30(3):355-410. PubMed ID: 23517220
[TBL] [Abstract][Full Text] [Related]
16. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study.
Hermida RC; Ayala DE; Mojón A; Fernández JR
Chronobiol Int; 2010 Sep; 27(8):1629-51. PubMed ID: 20854139
[TBL] [Abstract][Full Text] [Related]
17. Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.
Hermida RC; Ayala DE; Smolensky MH; Fernández JR; Mojón A; Portaluppi F
Hypertens Res; 2016 May; 39(5):277-92. PubMed ID: 26657008
[TBL] [Abstract][Full Text] [Related]
18. Administration-time differences in effects of hypertension medications on ambulatory blood pressure regulation.
Hermida RC; Ayala DE; Fernández JR; Mojón A; Smolensky MH; Fabbian F; Portaluppi F
Chronobiol Int; 2013 Mar; 30(1-2):280-314. PubMed ID: 23077971
[TBL] [Abstract][Full Text] [Related]
19. Bedtime hypertension treatment improves cardiovascular risk reduction: the Hygia Chronotherapy Trial.
Hermida RC; Crespo JJ; Domínguez-Sardiña M; Otero A; Moyá A; Ríos MT; Sineiro E; Castiñeira MC; Callejas PA; Pousa L; Salgado JL; Durán C; Sánchez JJ; Fernández JR; Mojón A; Ayala DE;
Eur Heart J; 2020 Dec; 41(48):4565-4576. PubMed ID: 31641769
[TBL] [Abstract][Full Text] [Related]
20. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
Hermida RC; Ayala DE; Fernández JR; Mojón A
Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
